Leuplinection and dizziness Patient Reports February 12, 2012

Leuplinection Side Effects Report #5055158-0
Leuplinection side effect was reported by a Consumer or non-health professional from JAPAN on June 29, 2006. Male patient, 73 years of age, was diagnosed with prostate cancer  and was treated with Leuplinection. After drug was administered, patient experienced the following side effects: blood testosterone decreased, bone marrow failure, bronchopulmonary aspergillosis, dizziness , febrile neutropenia, malaise, myelodysplastic syndrome, pneumonia . Leuplinection dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX, HALFDIGOXIN, CONIEL, LUPRAC. Patient was hospitalized. Patient died.